SCHEMBL7148696

SCHEMBL7148696

Oc1ccc(OCCc2ncc3ccccc3n2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYSLTR1 Q9Y271 6/20 0.41
▸ CYSLTR2 Q9NS75 4/20 0.41
▸ DRD4 P21917 2/20 0.41
▸ DRD2 P14416 1/20 0.41
▸ DRD3 P35462 1/20 0.41
▸ LMNA P02545 1/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ PTGS1 P23219 1/20 0.40
▸ SLC6A2 P23975 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ PTGS2 P35354 1/20 0.40
▸ SLC6A3 Q01959 1/20 0.40
▸ HIF1A Q16665 1/20 0.40
▸ HDAC6 Q9UBN7 1/20 0.40
▸ ESR1 P03372 1/20 0.39
▸ CYP19A1 P11511 1/20 0.39
▸ ESR2 Q92731 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ LTA4H P09960 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10669295 0.74 CYSLTR1 (0.57) CYSLTR1CYSLTR2L3MBTL1PDE10AGPBAR1
SCHEMBL8112158 0.73 PDE10A (0.47) CYSLTR1CYSLTR2LMNAPDE10AGPBAR1
SCHEMBL27595473 0.73 SMN1; SMN2 (0.51) CYSLTR1CYSLTR2LMNACYP1A2CYP2C19
SCHEMBL27863137 0.73 ALDH1A1 (0.36) CYSLTR1CYSLTR2CYP1A2MAPTPDE10A
SCHEMBL7074398 0.71 KDM4E (0.37) CYP1A2MAPTPDE10A
SCHEMBL28119918 0.71 TSHR (0.41) CYSLTR1CYSLTR2CYP1A2
SCHEMBL13726690 0.71 ALDH1A1 (0.43) DRD4DRD2DRD3HDAC6FFAR1
SCHEMBL6665065 0.71 LOXL2 (0.41) CYP1A2MAPTPDE10A
SCHEMBL9971271 0.71 KDM4E (0.44) LMNACYP1A2PDE10A
SCHEMBL5741619 0.71 KDM4E (0.39) CYSLTR1CYSLTR2CYP1A2MAPTPDE10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1345925-A2 PYRAZOLE COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2003-09-24 — — EP disclosed
WO-2002050065-A2 PYRAZOLE COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2002-06-27 — — WO disclosed
Send feedback